Precision BioSciences, Inc.DTILNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -90.93% | -99.84% | -99.96% | -97.74% | +5261.13% |
| Gross Profit Growth | -90.93% | -99.84% | -101.36% | -214.76% | +5154.86% |
| EBITDA Growth | +0.00% | -284.21% | -164.76% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | -190.60% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -339.46% | -171.82% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -235.29% | -145.32% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -234.71% | -145.61% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +53.51% | +76.64% | +58.56% | +62.18% | +87.71% |
| Weighted Average Shares Diluted Growth | +54.61% | +77.06% | +57.54% | +62.18% | +86.32% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -86.73% | -99.97% | -100.00% | -99.74% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -14.64% | -32.66% | -34.30% | -38.99% | +13.22% |
| Book Value per Share Growth | +94.77% | -24.93% | -71.25% | -84.19% | -12.85% |
| Debt Growth | -3.91% | -4.20% | -4.42% | -3.89% | -4.12% |
| R&D Expense Growth | +18.81% | +1.84% | -27.79% | -0.31% | -9.07% |
| SG&A Expenses Growth | +12.16% | +1.48% | +7.04% | -20.58% | -24.49% |